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Aim: We aimed to assess whether there was a correlation between the apnea–hypopnea index (AHI), desaturation time under 90%
(DTU-90), and mean saturation (MS) levels and the parameters associated with tissue hypoxia.
Materials and methods: A total of 144 subjects were included in the study. Blood C-reactive protein levels, blood uric acid levels,
and urine microalbumin levels were measured and the urine uric acid/creatinine ratio and urine microalbumin/creatinine ratio were
calculated.
Results: Our study results suggest that MS and DTU-90, as well as the AHI, are correlated with the parameters reflecting hypoxemia
and the other events secondary to hypoxia.
Conclusion: MS and DTU-90 may reflect the severity of disease and may be used in the first evaluation of a patient with suspicion of
obstructive sleep apnea before full polysomnography monitorization. Because they were not much better correlated with the parameters
than the AHI, it is difficult to make a claim for their use as the only tool, or their replacement of the AHI, in the evaluation of patients
with suspected obstructive sleep apnea.
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1. Introduction
Obstructive sleep apnea (OSA) syndrome is characterized
by recurrent episodes of partial or complete pharyngeal
collapse (hypopneas or apneas) occurring during sleep. It
is a growing health concern affecting up to 5% of middleaged males and females in the general population (1).
People with OSA have a night-time peak in occurrence
of sudden death and an increased rate of cardiovascular
morbidity and mortality (2–4).
The apnea–hypopnea index (AHI) or respiratory
disturbance index (RDI) are the common parameters used
to assess the severity of OSA (5). However, it is unclear
whether cases that have a longer duration of apnea and/
or hypopnea, or longer and/or more severe oxygen
desaturation levels, have the same disease severity as the
cases with shorter duration of apnea and/or hypopnea,
or shorter and/or less severe oxygen desaturation levels,
although they have similar AHI/RDI scores. Nevertheless,
it is reasonable to expect that the hypoxic damage caused
by an apnea or hypopnea event lasting for 10 s will not be
the same as an event lasting for more than 10 s. Similarly,
the hypoxic damage of a 4% desaturation and shorter event
* Correspondence: dromeraraz@gmail.com

may not be same as that of an event that has more than 4%
desaturation and is longer. There is a continuing debate as
to whether ambulatory monitorization tools, measuring
desaturation levels during the night, can be used instead of
polysomnographs (6).
In the current management of patients with OSA, that
AHI has been used, but desaturation level and duration
has not. However, the main problem for these patients
is hypoxia and the other events secondary to hypoxia,
such as sympathetic discharge, ischemia–reperfusion
injury, and production of reactive oxygen species during
reoxygenation (7,8). The effect of these events may
be evaluated by measuring serum C-reactive protein
(CRP) (9,10), blood uric acid levels and urine uric acid/
creatinine (UA/cr) ratio (11), microalbuminuria level, and
microalbuminuria/creatinine ratio (12–14).
With this study we aimed to assess whether there was
a correlation between AHI, desaturation time under 90%
(DTU-90), and mean saturation (MS) levels and the above
parameters associated with tissue hypoxia; to determine
whether DTU-90 and MS levels were better correlated with
those parameters than the AHI; and to discover whether or
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not they would be able to be used in determining disease
severity in the ambulatory monitorization of cases with
OSA suspicion instead of the AHI.
2. Materials and method
2.1. Study population
A total of 144 consecutive subjects (115 men and 29
women) with OSA were included in this study. Exclusion
criteria were regular medication, hypertension, chronic
heart failure, diabetes mellitus, chronic renal disease, and
pulmonary disease. Subjects who had smoking history of
1-pack-year or more and who had any infections at the
time of the study, or within the 2 weeks before the study,
were also excluded.
2.2. Measurements
After initial clinical evaluation a questionnaire was used to
obtain information about the subject’s history of snoring,
witnessed apnea, and excessive daytime sleepiness. The
Turkish version of the Epworth Sleepiness Scale was used
(15,16). A detailed physical examination was done and
anthropometric measurements, including neck and waist
circumference (cm), height (cm), weight (kg), and body
mass index (BMI, kg/m2), were obtained. Chest X-rays,
pulmonary function tests, electrocardiograms, and
echocardiograms were also obtained.
Hypertension was defined by a casual blood pressure
of ≥140/90 mmHg as according to the National Heart,
Lung, and Blood Institute criteria (17) or by current use of
antihypertensive agents. Diabetes mellitus was defined by
a fasting blood glucose level of ≥126 mg/dL. Obesity was
defined by a BMI of ≥25 kg/m2.
A venous blood sample and single void urine sample
were obtained in the morning after the completion of
polysomnography. Blood CRP levels, blood uric acid
levels, and urine microalbumin levels were measured.
Urine UA/cr ratios and urine microalbumin/creatinine
ratios were calculated. Blood uric acid, urinary uric acid,
and urinary creatinine measurements were determined
with the Cobas® 8000 Modular Analyzer Series (USA).
Blood CRP and urinary microalbumin analyses were
obtained by nephelometry (Siemens, Germany).
2.3. Sleep study
Full polysomnographic monitoring was performed with
the Compumedics E-series Sleep System (Compumedics
Sleep, Profusion 2, Australia). Electroencephalography
(EEG), electrooculography (EOG), electromyography
(EMG), and electrocardiography were performed
simultaneously. Surface electrodes were used to record
EEG channels (C3/A2, C4/A1, O1/A2, O2/A1), right and
left EOGs, and submental EMG. Ventilatory flow, either
at the nose or the nose and mouth, was measured with
airflow. Respiratory movements of the chest and abdomen,
and the body position, were monitored by inductive
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plethysmography bands. The arterial oxygen saturation
was measured transcutaneously with a finger oximeter.
Apnea was defined as continuous cessation of airflow for
≥10 s, and hypopnea was defined as at least a 50% reduction
of airflow for ≥10 s with an oxygen desaturation of ≥3%
or an EEG arousal from sleep. Apneas were classified as
obstructive, central, or mixed according to the standard
criteria of the American Academy of Sleep Medicine (4).
The study was planned according to the ethics
guidelines of the Helsinki Declaration and the study
protocol was approved by the local ethics committee.
2.4. Statistical analysis
The statistical analyses were performed with a statistical
software package (SPSS 17.0). All data are presented as
mean ± standard deviation for normally distributed data
and as median (quartile) for nonnormally distributed data.
The Kolmogorov–Smirnov test was used to test normality.
Correlations were determined using Pearson’s correlation
or Spearman’s correlation analysis when data were not
normally distributed. Because of skewed distribution of
the AHI, urine microalbumin, urine UA/cr, and urine
microalbumin/creatinine, they were log-normalized
before correlation analysis. To examine whether blood
uric acid, CRP, urine microalbumin, urine UA/cr, and
urine microalbumin/creatinine were correlated with AHI,
MS, or DTU-90, we calculated Pearson’s or Spearman’s
correlation coefficients. In the case of a significant
correlation, we performed a multiple regression analysis
to determine whether the correlation persisted after
controlling for BMI, sex, and age. Values of P < 0.05 were
considered statistically significant.
3. Results
A total of 144 subjects, 115 (79.8%) men and 29 (20.2%)
women with mean age of 47.2 ± 11.6 years, were included
in the study. Demographic characteristics and laboratory
findings of the subjects were shown in Table 1.
All of the studied parameters, blood uric acid, CRP,
urine microalbumin, urine microalbumin/creatinine
ratio, and UA/cr ratio were positively correlated with AHI,
MS, and DTU-90 (Table 2). The correlations between
them, except that between blood uric acid and AHI, were
statistically significant (Figures 1A–1C). However, the
correlations between urine microalbumin and AHI, MS,
and DTU-90, and between microalbumin/creatinine and
DTU-90, remained after controlling for confounding
factors such as age, sex, and BMI (Table 3). The most
important factor affecting the results was BMI.
4. Discussion
Our study results suggest that MS and DTU-90 were
correlated with the parameters, reflecting hypoxemia and
the other events secondary to hypoxia as well as the AHI.
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Table 1. Demographic characteristics and laboratory findings of the subjects.
Age

47.2 ± 11.6

BMI (kg/m )

30.5 ± 5.8

Neck circumference (cm)

40.7 ± 3.2

Waist circumference (cm)

105.8 ± 13.3

AHI

30 (14–50)

Mean saturation

5 (4–7)

DTU-90 (min)

72 (15–217)

Blood uric acid

5.18 ± 1.63

CRP

0.317 (0.302–0.404)

Urine microalbumin

13.0 (8.3–19.0)

Microalbumin/creatinine

0.09 (0.06–0.15)

UA/cr

0.45 (0.37–0.54)

2

Data are presented as mean ± standard deviation or median (quartile). BMI: Body mass
index, AHI: apnea–hypopnea index, DTU-90 (min): desaturation time under 90%,
CRP: C-reactive protein, UA/cr: uric acid/creatinine ratio.
Table 2. The correlation between the studied parameters and the AHI, MS, and DTU-90.
AHI

MS

DTU-90

R

P

R

P

R

P

Blood uric acid

0.118

0.079

0.196*

0.009

0.259*

0.001

CRP

0.192*

0.011

0.232*

0.005

0.155*

0.032

Urine microalbumin

0.230*

0.003

0.241*

0.002

0.269*

0.001

Microalbumin/creatinine

0.226*

0.03

0.225*

0.003

0.332*

<0.0001

UA/cr

0.156*

0.031

0.164*

0.025

0.148*

0.038

AHI: Apnea–hypopnea index, MS: mean saturation, DTU-90 (min): desaturation time under 90%, CRP: C-reactive protein, UA/cr: uric
acid/creatinine ratio. *Statistically significant.

They may reflect the severity of disease and may be used in
the first evaluation of a patient with the suspicion of OSA
before full polysomnographic monitorization. Because
they were not much better correlated with the parameters
than the AHI, it is difficult to claim their use as the only
tool, or their replacement of the AHI, in the evaluation of
the patients with suspected OSA.
To observe the effect of hypoxia, we used the parameters
associated with hypoxia, including serum CRP levels,
blood uric acid levels, UA/cr, urine microalbumin levels,
and microalbumin/creatinine ratio. Blood CRP levels are
used in the evaluation of inflammation. In OSA patients,
elevated serum CRP levels, as a marker of inflammation

and the independent relationship between the severity
of disease, have been reported in previous studies (9,10).
Blood uric acid levels and UA/cr ratio were used as
noninvasive and inexpensive markers of oxidative stress.
Both are suggested to be markers of tissue hypoxia in OSA
patients (11). Each episode of airway obstruction followed
by hypoxemia causes episodes of ischemia–reperfusion
injury. Such damage is mainly attributed to the production
of reactive oxygen species during reoxygenation (7,8).
This damage causes increased blood uric acid levels and
the excretion of uric acid. To assess the vascular damage,
urine microalbumin levels were measured and the urine
microalbumin/creatinine ratio was calculated. The
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Figure 1. The correlation between blood uric acid and apnea–hypopnea index (A), mean saturation (B), and desaturation time under
90% (C).

Table 3. The correlation between the studied parameters and the AHI, MS, and DTU-90 after correction for the confounding factors,
age, sex, and BMI.
AHI

MS

DTU-90

β

P

β

P

β

P

NA

NA

0.047

0.573

0.088

0.312

CRP

0.157

0.070

0.073

0.415

0.102

0.280

Urine microalbumin

0.172*

0.040

0.176*

0.046

0.226*

0.017

Microalbumin/creatinine

0.013

0.071

0.017

0.229

0.235*

0.012

UA/cr

0.198

0.054

0.128

0.094

0.074

0.117

Blood uric acid

AHI: Apnea–hypopnea index, MS: mean saturation, DTU-90 (min): desaturation time under 90%, CRP: C-reactive protein, UA/cr: uric
acid/creatinine ratio. *Statistically significant. To provide the importance of a predictor, the standardized beta values (β) were measured
after entering age, sex, and BMI variables into the model. NA: Not accounted.
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vascular dysfunction caused by the endothelial damage
leads to albumin loss from kidneys. Microalbuminuria has
been described in hypertensive or diabetic patients as a
marker of target organ damage and was evaluated in OSA
patients in several studies (12–14).
The mechanism for increased risk of cardiovascular
diseases in patients with OSA is unclear; it is more likely
to result from increased sympathetic activation, oxidative
stress, inflammation, and systemic vascular endothelial
dysfunction. We found a positive correlation between
blood uric acid and the AHI, MS, and DTU-90, but the
correlation was not significant for the AHI. It is known that
blood uric acid levels are related to OSA severity (18). In
previous studies, the correlations between blood uric acid
and some oxidative parameters such as AHI, desaturation
index, cumulative percentage of time with SpO2 less than
90%, DTU-90, and mean SpO2 were determined and
positive correlations for each of them were reported (19–
21). In these studies the correlations were confounded by
obesity, as in ours. This is thought to be due to the effect
of the concomitant obesity of OSA patients. A higher BMI
generally causes more severe OSA.
The overnight change of urinary uric acid secretion
was also measured many years ago, and it was suggested
to be a good index of tissue hypoxia (22). In our study
we found that the urine UA/cr ratio correlated with the
AHI, MS, and DTU-90 and also found that these were
confounded with BMI, like in blood uric acid results.
There is no full compatibility in previous studies that
evaluated uric acid excretion in OSA patients. In 2 of
these, a significant increase in the urinary UA/cr ratio
was observed in association with nocturnal hypoxemia;
continuous positive airway pressure treatment led to a
significant reduction in this ratio (22,23). Some other
studies failed to confirm this observation (24) and no
significant correlation was found between urinary UA/cr
ratio and AHI (25). To validate the urinary UA/cr ratio
as a marker of nocturnal hypoxemia, normal subjects,
OSA patients, and chronic obstructive pulmonary disease
patients were compared and the overnight change in the
urinary UA/cr was confirmed to be a promising index of
significant nocturnal tissue hypoxia (11).
The elevated level of CRP in OSA patients due to
increased inflammation was previously known. It is one
of the proinflammatory proteins and an important risk
factor for atherosclerosis. In our study subjects, CRP was
positively correlated with AHI, MS, and DTU-90, and the
significance was confounded by BMI. In previous studies,
the relation between increased CRP levels and OSA was
shown, but the effect of obesity on this relation differed
in various studies. Taheri et al. described a significant
positive association between CRP levels and the AHI, but
these relationships were not significant after adjustment

for age, sex, and BMI (26). The positive correlations with
AHI, duration of O2 saturation < 90%, and arousal index
and negative correlation with minimal O2 saturation were
reported in a study independent of visceral obesity (27).
Another recent study concluded high sensitive CRP levels
were associated with AHI, independent of obesity in OSA
patients (28).
The relationship between OSA and microalbuminuria
is not certain. The present study indicates a positive
correlation between microalbuminuria and AHI, MS, and
DTU-90 among OSA patients. The association between
OSA and albuminuria was shown with hypertensive
patients, and albuminuria was found to be greater by
57% in patients with OSA compared with those without
OSA (29). Ursavas et al. found urinary albumin excretion
significantly higher among normotensive, nondiabetic
patients in an OSA group as compared with a control group.
They also found albumin excretion positively correlated to
the length of time spent at an oxygen saturation of <90%,
independent of age and BMI (14). There were also studies
that found that microalbuminuria was not related to
sleep-disordered breathing. Buchner et al. compared renal
function in OSA patients with and without hypertension
and concluded that microalbuminuria was not associated
with OSA (30). Another study among overweight and
obese children and adolescents found no difference
in albumin excretion rate between subjects with and
without sleep-disordered breathing, and none of the sleepdisordered breathing parameters were correlated with
transformed albumin excretion (31). It was concluded that
in obese adults, increasing severity of OSA was associated
with higher serum creatinine but not greater degrees of
albuminuria (32).
The urine microalbumin/creatinine ratio is generally
used to evaluate the renal functions for target organ
damage in OSA patients. In our study, the microalbumin/
creatinine ratio was positively correlated with the AHI,
DTU-90, and MS. The correlations of AHI and MS were
insignificant after controlling for age, sex, and BMI; this
was basically caused by the effect of BMI, which is to say
the effect of obesity, on OSA. Both OSA and obesity have
been associated with similar effects on the kidney, like
glomerulomegaly and focal segmental sclerosis (33,34). As
validation, Tsioufis et al. measured the albumin/creatinine
ratio (ACR) from 2 nonconsecutive spot urine samples
of patients with and without OSA and found the AHI to
be the independent predictor of the ACR (27). In another
study population, the urine albumin/creatinine ratio was
not different between the subjects with OSA and those
without OSA (32).
Our study aimed to show whether MS and DTU90 reflect the tissue hypoxia and sympathetic discharge
(vascular dysfunction and endothelial damage) that
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occurred in OSA as did the AHI. Our study showed that
MS and DTU-90 were as well correlated as the AHI within
the parameters studied, as shown by previous studies. Our
findings suggest that ambulatory monitorization may be

used as a screening test in OSA, because the parameters
that they use are well correlated with the AHI and may
decrease the work-load of sleep laboratories because of
their convenience and cheapness.
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